Drug intelligence / Profile preview

Qingke Pingchuan Granule

Development stage
Unknown
Lead developer
Changchun Leiyunshang Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Qingke Pingchuan Granule is a Traditional Chinese Medicine (TCM) hospital preparation developed by Jiangsu Shengze Hospital (Affiliated Shengze Hospital of Nanjing Medical University) for the treatment of community-acquired pneumonia (CAP). It is specifically indicated for patients presenting with the 'phlegm-heat obstructing lung' syndrome, a common TCM pattern in respiratory infections characterized by cough, fever, and dyspnea. The formulation is designed to clear pulmonary heat, resolve phlegm, and alleviate wheezing. Clinical observations suggest that the granule, when used as an adjunctive therapy, can reduce systemic inflammatory markers such as C-reactive protein (CRP), Interleukin-6 (IL-6), and Tumor Necrosis Factor-alpha (TNF-α), thereby improving clinical recovery rates and accelerating the resolution of pulmonary inflammation.

Other names
Qingke Pingchuan Keli清咳平喘颗粒
02

Targets

NCF1 (Neutrophil cytosolic factor 1)

Beyond the preview

Go deeper on Qingke Pingchuan Granule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qingke Pingchuan Granule.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call